Coagulation Disorders

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

BLOOD CLOTTING, FORMATION, & DISORDERS February 19-20, 2015.
Drugs for Coagulation Disorders
Lecture – 3 Dr. Zahoor Ali Shaikh
Drugs for Coagulation Disorders Andrew N. Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University October 8, 2008
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
Blood Clotting Robin Gray.
Bleeding time,clotting time, PT, and PTT
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
BLOOD A - BODY FLUIDS B - BLOOD I- Function II- Composition III- Hemostasis IV- Blood group.
Anticoagulation in the Acute Care Population Aimee Ring PT, DPT, GCS.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Hemostasis and Blood Coagulation
FUNCTIONS OF THE COAGULATION SYSTEM ACTIONDESIRED RESULT Rapid formation of mechanically sound clot Stop bleeding quickly Prevent clot formation at non-injured.
Implant of a Medical Device and the Wound Healing Process.
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
Dr Mahvash Khan MBBS, MPhil. ◦ Occurs inside the blood vessels, it is also called fibrinolysis ◦ Occurs due to a substance known as plasmin (fibrinolysin)
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
Chapter 12 Blood Edited by Dr. Ryan Lambert-Bellacov.
Objectives 1. Describe the primary function of blood 2. Describe the characteristics of blood plasma 3. Identify the formed elements of blood and identify.
Blood Made of Made of –Plasma 55%– liquid part of blood (water, proteins) –Formed elements 45%– rbc’s, wbc’s, platelets –Buffy coat – wbc and platelets.
Hematopoiesis & Hemostasis
Drugs for Coagulation disorders. There are a number of different categories of drugs which modify the coagulation process: I. Anticoagulants II. Antiplatelet.
Hemostasis. Hemostasis Definition Prevention of blood loss (stoppage of blood flow)
NECESSITY FOR BLOOD CLOTTING SEALS A WOUND PREVENT EXCESSIVE BLOOD LOSS FROM THE BODY PREVENTS THE ENTRY OF MICROORGANISMS AND FOREIGN PARTICLES INTO THE.
Copyright © 2009 Pearson Education, Inc., publishing as Benjamin Cummings Hematopoiesis  Blood cell formation  Occurs in red bone marrow  About one.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
17 Blood.
Blood Chapter 19 (H). What does blood do? Transports substances around the body to maintain homeostasis Transports substances around the body to maintain.
Drugs Used to Treat Thromboembolic Disorders Chapter 27 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 56 Blood-Forming Drugs.
Chapter 10 Blood. Physical Characteristics Fluid –Living 45% Cells –RBC Erythrocytes (carry oxygen) –WBC Leukocytes (immune) –Platelets (clotting) –Non.
Agents Affecting Blood Clotting
ERYTHROCYTE II (Anemia Polycythemia)
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
Erythrocyte Disorders Read through these in your notes and in your text to make sure you understand the causes and/or symptoms They will be on your Quiz.
Hemostasis and Coagulation Hemostasis Hemostasis is the maintenance of circulating blood in the liquid state and retention of blood in the vascular system.
Blood Keri Muma Bio 6. Functions of Blood Transport  Oxygen and nutrients to the cells  Waste away from cells  Hormones Regulation  Maintain body.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Blood Pathologies. Components of Whole Blood Figure 17.2.
Hematopoiesis Blood cell formation Occurs in red bone marrow.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
23 Anticoagulants.
CHAPTER 17 BLOOD.
Blood Made of Average person 4-6L 7.4 pH, acidosis if falls below 7.35
The Hematologic and Lymphatic Systems and Assessment
Why is blood so important to survival?
Capillary Action and Blood Components
Hematopoiesis and Hemostasis
The pathology of cardiovascular disease (CVD)
What does blood do? Transport: Regulation: Protection:
Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College
Coagulation Modifier Drugs
Blood.
Implant of a Medical Device and the Wound Healing Process.
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
UNIT 3 NOTES: Hematopoiesis & Hemostasis
ANATOMY Unit 3 Notes: Hematopoiesis & Hemostasis
Transportation & Circulatory System
Introduction Physiology is the study of the living things
Hematology and Coagulation Procedures
23 Anticoagulants.
Drugs Affecting Blood.
Chapter 12 Blood.
Blood Disorder: Hemophilia
Presentation transcript:

Coagulation Disorders

Drugs Anticoagulants Antiplatelets Thrombolytics Hemostatics Parenteral = Heparin Enteral = Warfarin Antiplatelets Clopidogrel (Plavix) Thrombolytics Alteplase (activase) Hemostatics Amicar

Hemostasis Stopping of blood flow Involves large number of enzymes and clotting factors Final product is a fibrin clot that stops blood loss

Figure 27.1 Basic Steps in Hemostasis Platelets gather at wound & attempt to block blood flow Calcium, Vitamin K, fibrinogen help platelets form clot when exposed to air Fibrinogen fibrin, weblike mesh trapping blood cells in “scab”

Coagulation Cascade Injured cells release prothrombin activator Prothrombin activator changes prothrombin to thrombin. Thrombin changes fibrinogen to fibrin Fibrin forms insoluble web over injured area to stop blood flow

Fibrinolysis Clot removal Initiated by release of tissue plasminogen activator (tPA) tPA converts plaminogen to plasmin Plasmin digests fibrin strands – thus, circulation is restored Regulated so unwanted clots are removed and fibrin is left in wounds

Diseases of Hemostasis Thromboembolic disorders (need anticoagulants) Thrombus, embolus DVT Thrombocytopenia Bleeding disorders (Hemophilia)

Coagulation Modifiers Anticoagulants Thrombolytics Hemostatics

Lab Tests that Measure Coagulation Used for diagnosing and treating coagulation disorders Prothrombin time (PT) International normalized ratio (INR) Thrombin time Activated partial thromboplastin (aPTT) Liver function tests Bleeding time Platelet count (CBC)

Role of Nurse ANTICOAGULANTS Most serious side effect to assess is bleeding To assess internal bleeding Monitor CBC, abdominal bulging, guaiac tests on stool Essential for patient safety to assess coagulation studies Monitor intake of vitamin K-rich foods; limit intake of garlic Heparin (Heplock) Indirect thrombin inhibitor; Warfarin (Coumadin) Vitamin K Antagonist

Role of Nurse ANTIPLATELET AGENTS Monitor for bleeding Risk increases if given with anticoagulants Prolonged pressure needed to control bleeding at puncture sites Clopidogrel (Plavix) Antiplatelet drug

Role of Nurse THROMBOLYTICS To dissolve existing clots To treat acute myocardial infarction, deep vein thrombosis To treat cerebrovascular accident, pulmonary embolism, arterial thrombosis To clear IV catheters Alteplase (Activase)

Role of Nurse HEMOSTATICS To promote formation of clots by preventing and treating excessive bleeding from surgical sites Aminocaproic Acid (Amicar)

Hematopoietic Disorders

Drugs Hematopoietic Growth Factors Antianemic Drugs Erythropoietin aka epoeitin alfa (Epogen) Colony stimulatin aka filgrastim (Neuopogen) Antianemic Drugs Cyanocobalamin (Nascobal) Ferrous sulfate

HEMATOPOIESIS Process of blood-cell formation Begins with stem cell in bone marrow Erythrocytes (erythropoiesis) –RBC Leukocytes (leukopoiesis) –WBC Platelets (thrombocytopoiesis)

Hematopoiesis

Anemias Blood has reduced capacity to carry oxygen Erythrocyte loss due to hemorrhage Excessive erythrocyte destruction Impaired erythrocyte production Anemia is a sign, not a distinct disease

Anemias Classification of Anemias Common Signs and Symptoms A description of the erythrocyte’s size and color. Sizes are described as normal (normocytic) small (microcytic large (macrocytic). Color is based on the amount of hemoglobin present and described as normal red (normochromic) or light red (hypochromic). Pallor of skin and mucus membranes Decreased exercise tolerance Fatigue and lethargy, dizziness and fainting Increased respiratory rate and heart rate Heart failure

Vitamin B12 Deficiency = Pernicious or Megaloblastic Absence of intrinsic factor, protein secreted by stomach cells required for Vitamin B12 to be absorbed from intestines. Vitamin B12 & Folic Acid

Iron Deficiency Anemia Iron is an important building block for red blood cells. Without iron, blood cannot carry oxygen effectively.

Role of the Nurse Careful monitoring of client’s condition Providing education as it relates to prescribed drug treatment Assess medical, drug, dietary, and lifestyle history Obtain baseline complete blood count and vital signs

Prototype Drugs Epoetin Alfa (Epogen, Procrit) –anemia Filgastrim (Neupogen) –increase neutrophil production Cyanocobalamin (Vitamin B12) –anemia/vitamin supplement Ferrous Sulfate (Feosol) –anemia/iron supplement